NCT02563548 2020-02-07A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid TumorsHalozyme TherapeuticsPhase 1 Completed56 enrolled 24 charts
NCT03267940 2020-02-07Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder AdenocarcinomaHalozyme TherapeuticsPhase 1 Terminated85 enrolled 17 charts